Giampiero Girolomoni

Research interests

Publications

• European guideline ( EuroGuiDerm ) on atopic eczema – part II : non‐systemic treatments and treatment recommendations for special AE patient populations

  Journal of the European Academy of Dermatology and Venereology · 2022 · 10.1111/jdv.18429

• European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy

  Journal of the European Academy of Dermatology and Venereology · 2022 · https://doi.org/10.1111/jdv.18345

• Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II

  Journal of the European Academy of Dermatology and Venereology · 2018 · https://doi.org/10.1111/jdv.14888

• The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis

  Frontiers in Immunology · 2018 · 10.3389/fimmu.2018.01549

• Epidemiology of atopic dermatitis in adults: Results from an international survey

  Allergy · 2018 · https://doi.org/10.1111/all.13401

• Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I

  Journal of the European Academy of Dermatology and Venereology · 2018 · https://doi.org/10.1111/jdv.14891

• Psoriasis and the metabolic syndrome

  Clinics in Dermatology · 2017 · 10.1016/j.clindermatol.2017.09.005

• The role of IL ‐23 and the IL ‐23/ T H 17 immune axis in the pathogenesis and treatment of psoriasis

  Journal of the European Academy of Dermatology and Venereology · 2017 · https://doi.org/10.1111/jdv.14433

• Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)

  British Journal of Dermatology · 2015 · 10.1111/bjd.14164

• Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey

  Journal of the American Academy of Dermatology · 2014 · https://doi.org/10.1016/j.jaad.2013.12.018

• Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions

  Journal of Investigative Dermatology · 2010 · https://doi.org/10.1038/jid.2010.103

• European S3‐Guidelines on the systemic treatment of psoriasis vulgaris

  Journal of the European Academy of Dermatology and Venereology · 2009 · https://doi.org/10.1111/j.1468-3083.2009.03389.x

• Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis

  Journal of Hepatology · 2009 · 10.1016/j.jhep.2009.04.020

• Drug-induced lupus erythematosus

  Archives of Dermatological Research · 2008 · 10.1007/s00403-008-0895-5

• Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment

  The Journal of Experimental Medicine · 2008 · 10.1084/jem.20080129

• Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial

  American Journal of Clinical Nutrition · 2008 · 10.3945/ajcn.2008.26427

• The Epidermal Growth Factor Receptor System in Skin Repair and Inflammation

  Journal of Investigative Dermatology · 2007 · 10.1038/sj.jid.5701184

• Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case?control study

  British Journal of Dermatology · 2007 · 10.1111/j.1365-2133.2007.07986.x

• CD56brightCD16– NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation

  European Journal of Immunology · 2005 · 10.1002/eji.200535243

• Blockade of the EGF Receptor Induces a Deranged Chemokine Expression in Keratinocytes Leading to Enhanced Skin Inflammation

  American Journal Of Pathology · 2003 · 10.1016/s0002-9440(10)63654-1

• Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells

  Blood · 2003 · 10.1182/blood-2002-07-2113

• Regulatory Activity of Autocrine IL-10 on Dendritic Cell Functions

  The Journal of Immunology · 2001 · 10.4049/jimmunol.166.7.4312

• Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell–derived cytokines

  Journal of Allergy and Clinical Immunology · 2001 · 10.1067/mai.2001.114707

• Interleukin-17 is Produced by Both Th1 and Th2 Lymphocytes, and Modulates Interferon-γ- and Interleukin-4-Induced Activation of Human Keratinocytes

  Journal of Investigative Dermatology · 2000 · 10.1046/j.1523-1747.2000.00041.x

• IL-17 Is Produced by Nickel-Specific T Lymphocytes and Regulates ICAM-1 Expression and Chemokine Production in Human Keratinocytes: Synergistic or Antagonist Effects with IFN-γ and TNF-α

  The Journal of Immunology · 1999 · 10.4049/jimmunol.162.1.494

Current projects

No projects listed.